Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood (glycemia). Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The other main option is continuous glucose monitoring (CGM). Different manufacturers use different technology, but most systems measure an electrical characteristic and use this to determine the glucose level in the blood. Skin-prick methods measure capillary blood glucose, whereas CGM correlates interstitial fluid glucose level to blood glucose level. Measurements may occur after fasting or at random nonfasting intervals, each of which informs diagnosis or monitoring in different ways.
A glucose meter, also referred to as a "glucometer", is a medical device for determining the approximate concentration of glucose in the blood. It can also be a strip of glucose paper dipped into a substance and measured to the glucose chart. It is a key element of glucose testing, including home blood glucose monitoring (HBGM) performed by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained from slightly piercing a fingertip with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in units of mg/dL or mmol/L.
The main goal of diabetes management is to keep blood glucose (BG) levels as normal as possible. If diabetes is not well controlled, further challenges to health may occur. People with diabetes can measure blood sugar by various methods, such as with a BG meter or a continuous glucose monitor, which monitors over several days. Glucose can also be measured by analysis of a routine blood sample. Usually, people are recommended to control diet, exercise, and maintain a healthy weight, although some people may need medications to control their blood sugar levels. Other goals of diabetes management are to prevent or treat complications that can result from the disease itself and from its treatment.
Diabetes Management Software refers to software tools that run on personal computers and personal digital assistants to help persons with Type 1 and Type 2 diabetes manage the data associated with:
Wrike, Inc. is an American project management application service provider based in San Jose, California. Wrike also has offices India, Dallas, Tallinn, Nicosia, Dublin, Tokyo, Melbourne, and Prague.
DrChrono is an American digital health technology company that provides software and billing services on a platform of web apps and cloud-based apps for doctors and patients. The company makes electronic health records (EHR), practice management software, and medical billing software and provides medical revenue cycle management (RCM) services. The company is based in Sunnyvale, California.
Withings is a French consumer electronics company headquartered in Issy-les-Moulineaux, France. It also has offices in Boston, Massachusetts, USA, and Hong Kong, and distributes its products worldwide. Withings is known for design and innovation in connected devices, such as the first Wi-Fi scale on the market, an FDA-cleared blood pressure monitor, a smart sleep system, and a line of automatic activity tracking watches. It also provides B2B services for healthcare providers and researchers.
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland.
A mobile application or app is a computer program or software application designed to run on a mobile device such as a phone, tablet, or watch. Mobile applications often stand in contrast to desktop applications which are designed to run on desktop computers, and web applications which run in mobile web browsers rather than directly on the mobile device.
Microsoft SwiftKey is a virtual keyboard app originally developed by TouchType for Android and iOS devices. It was first released for Android in July 2010, followed by an iOS release in September 2014 after Apple's implementation of third-party keyboard support.
Samsung Knox is a proprietary security and management framework pre-installed on most Samsung mobile devices. Its primary purpose is to provide organizations with a toolset for managing work devices, such as employee mobile phones or interactive kiosks. Samsung Galaxy hardware, as well as software such as Secure Folder and Samsung Wallet, make use of the Knox framework.
Azumio is a mobile health company that specializes in biometric mobile technology. Founded in 2011, Azumio develops Apple iOS and Android health apps and services. Azumio has released 24 apps on iOS, 5 apps on Android, and 3 apps on Windows Phone. The company is headquartered in Palo Alto, California.
Good Technology, owned by BlackBerry Limited, is a mobile security provider headquartered in Sunnyvale, California, United States. The company serves more than 5,000 organizations worldwide in industries such as financial services, healthcare, manufacturing, energy and utilities, legal, government, and technology. Good makes products for managing and securing mobile devices in a business environment. The company focuses on securing apps and data on mobile devices.
Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
Nightscout is a free and open-source project, and associated social movement, that enables accessing and working with continuous glucose monitor (CGM) data. Nightscout software aims to give users access to their real time blood sugar data by putting this data in the cloud. In addition to browser-based data visualization, Nightscout can also be used to review data from a phone or smartwatch, or to remotely monitor CGM data for individuals with type 1 diabetes. Associated with Nightscout software is a broader "CGM in the Cloud" social movement, supporting individuals seeking to access and use realtime CGM data through commercial and DIY approaches.
A continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis instead of monitoring glucose levels periodically by drawing a drop of blood from a finger. This is known as continuous glucose monitoring. CGMs are used by people who treat their diabetes with insulin, for example people with type 1 diabetes, type 2 diabetes, or other types of diabetes, such as gestational diabetes.
AppSheet is a no-code development platform for application software, which allows users to create mobile, tablet, and web applications. It allows using data sources like Google Drive, DropBox, Office 365, and other cloud-based spreadsheet and database platforms. AppSheet can be utilized for a broad set of business use cases including project management, customer relationship management, field inspections, and personalized reporting. AppSheet was acquired by Google in January 2020.
Google Messages is a text messaging software application developed by Google for its Android and Wear OS mobile operating systems. It is also available as a web app.
Lark Health is an American digital health company based in Mountain View, California. It provides a 24/7 nursing platform for chronic conditions, powered by artificial intelligence (AI) and has a text-messaging type interface. Lark also provides AI nurses for type 2 diabetes care, hypertension care, tobacco cessation, stress management, obesity, and more for 1.5 million patients.
